Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms

Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms

Abstract Background Despite timely administration of IVIG, some patients with Kawasaki disease (KD) develop rapidly progressive or giant coronary artery aneurysms (CAA). Case presentation We describe our experience using cyclophosphamide (CYC) for the treatment of such cases as well as a review of t...

Full description

Bibliographic Details
Main Authors: Olha Halyabar, Kevin G. Friedman, Robert P. Sundel, Annette L. Baker, Margaret H. Chang, Patrick W. Gould, Jane W. Newburger, Mary Beth F. Son
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Kawasaki disease
Coronary artery aneurisms
Treatment
Immunosuppression
Cyclophosphamide
Online Access:https://doi.org/10.1186/s12969-021-00526-0

Internet

https://doi.org/10.1186/s12969-021-00526-0

Similar Items